Epigenetic Mechanisms in Neurofibromatosis Types 1 and 2.

Area of Science:

• Neurogenetics
• Epigenetics
• Oncology

Background:

• Neurocutaneous syndromes, or phakomatoses, include neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2), genetic disorders affecting the nervous system and skin.
• While germline mutations in NF1 and NF2 genes are known, they don't fully explain the wide clinical variability.
• Epigenetic mechanisms are increasingly recognized for their role in modulating gene expression and disease severity.

Purpose of the Study:

• To review and organize current knowledge on epigenetic alterations in NF1 and NF2.
• To emphasize the impact of epigenetic changes on disease behavior.
• To highlight the potential of epigenetic modifications as prognostic biomarkers and therapeutic targets.

Main Methods:

• Literature review and synthesis of existing research on neurofibromatosis and epigenetics.
• Analysis of epigenetic mechanisms such as DNA methylation, histone modifications, chromatin remodeling, and ncRNA regulation.
• Focus on how these mechanisms influence gene expression and disease phenotype.

Main Results:

• Epigenetic mechanisms play a critical role in modulating gene expression in NF1 and NF2.
• These mechanisms contribute to the broad clinical variability observed in patients, even those with identical mutations.
• Fragmented research highlights the need for a unified model of epigenetic influence.

Conclusions:

• Epigenetic alterations significantly impact the behavior and severity of NF1 and NF2.
• Further understanding of these epigenetic changes is crucial for developing personalized management strategies.
• Epigenetic modifications represent promising targets for novel therapeutic interventions in neurofibromatosis.